Cited by 317Hormonal and reproductive studiesDiabetes, Cardiovascular Risks, and LipoproteinsSperm and Testicular Function

The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.

Androgens, insulin resistance and vascular disease in men

Kapoor, D., Malkin, C. J., Channer, K. S., Jones, T. H.·2005·Clinical Endocrinology

Abstract

Summary: Type 2 diabetes mellitus is increasing globally and is an established risk factor for the development of atherosclerotic vascular disease. Insulin resistance is the hallmark feature of type 2 diabetes and is also an important component of the metabolic syndrome. There is evidence to suggest that testosterone is an important regulator of insulin sensitivity in men. Observational studies have shown that testosterone levels are low in men with diabetes, visceral obesity (which is strongly associated with insulin resistance), coronary artery disease and metabolic syndrome. Short‐term interventional studies have also demonstrated that testosterone replacement therapy produces an improvement in insulin sensitivity in men. Thus hypotestosteronaemia may have a role in the pathogenesis of insulin‐resistant states and androgen replacement therapy could be a potential treatment that could be offered for improvements in glycaemic control and reduction in cardiovascular risk, particularly in diabetic men.

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2005.02299.x

Cites

120 of 120 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 120 references

Research works printed but not linked: 10

  1. 10.1080/713602987 · DOI
  2. 10.1210/jc.85.9.3276 · DOI
  3. 10.1210/jc.76.2.279 · DOI
  4. 10.1210/jc.79.1.265 · DOI
  5. Thaddea S., 1940, The effect of the sex hormones on metabolism in diabetes of late onset, Klinicheskaia Meditsina, 137, 760
  6. 10.1210/jc.74.2.362 · DOI
  7. 10.1210/jc.80.11.3373 · DOI
  8. 10.1080/713604785 · DOI
  9. Rayner M., 1998, British Heart Foundation Statistics Database
  10. Pugh P.J., 2003, High prevalence of low testosterone levels in men with coronary heart disease and an association with hypertension and obesity, Endocrine Abstracts, 5, P225

Cited by

Sorted by citations

Items 301–317 of 317

Metadata

Authors
Kapoor, D., Malkin, C. J., Channer, K. S., & Jones, T. H.
Affiliations
  • Barnsley Hospital NHS Foundation Trust (GB)
  • Royal Hallamshire Hospital (GB)
Corresponding author
Jones, T. H.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2005-06-15
Volume
63
Issue
3
Pages
239-250
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2137783284
Cited by
317
References
120
Citations by year
2026: 3 · 2025: 6 · 2024: 13 · 2023: 8 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 7 · 2018: 12 · 2017: 8 · 2016: 10 · 2015: 16 · 2014: 23 · 2013: 13 · 2012: 23
FWCI
3.27
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
Keywords
androgens, testosterone, insulin resistance, type 2 diabetes, atherosclerosis, coronary artery disease, metabolic syndrome, visceral obesity, hypogonadism, testosterone replacement therapy, glycemic control, cardiovascular risk, men
MeSH terms
Aged, Aging, Arteriosclerosis, Dehydroepiandrosterone, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Male, Middle Aged, Obesity, Sex Hormone-Binding Globulin, Testosterone, Vascular Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review